TRIGGIANESE, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 18.625
AS - Asia 3.587
EU - Europa 2.551
Continente sconosciuto - Info sul continente non disponibili 452
SA - Sud America 445
AF - Africa 101
OC - Oceania 87
Totale 25.848
Nazione #
US - Stati Uniti d'America 18.383
SG - Singapore 1.603
CN - Cina 754
IT - Italia 553
RU - Federazione Russa 421
BR - Brasile 354
HK - Hong Kong 352
VN - Vietnam 244
DE - Germania 243
IE - Irlanda 221
FR - Francia 213
GB - Regno Unito 189
FI - Finlandia 180
BD - Bangladesh 153
UA - Ucraina 139
CA - Canada 120
JP - Giappone 107
SE - Svezia 87
IN - India 66
NL - Olanda 62
PL - Polonia 51
KR - Corea 46
AU - Australia 44
NZ - Nuova Zelanda 43
ID - Indonesia 40
DK - Danimarca 38
ES - Italia 35
TW - Taiwan 35
BE - Belgio 32
MX - Messico 32
TR - Turchia 32
AR - Argentina 31
ZA - Sudafrica 28
EG - Egitto 26
AT - Austria 22
SA - Arabia Saudita 20
EC - Ecuador 18
CR - Costa Rica 16
IR - Iran 15
JM - Giamaica 13
CO - Colombia 12
MA - Marocco 12
PH - Filippine 12
UZ - Uzbekistan 12
IQ - Iraq 11
LV - Lettonia 11
MY - Malesia 11
AE - Emirati Arabi Uniti 10
NP - Nepal 10
PK - Pakistan 10
HN - Honduras 9
IL - Israele 9
TT - Trinidad e Tobago 9
LT - Lituania 8
SC - Seychelles 8
CH - Svizzera 7
GP - Guadalupe 7
GT - Guatemala 7
NG - Nigeria 7
PR - Porto Rico 7
VE - Venezuela 7
CL - Cile 6
NI - Nicaragua 6
PE - Perù 6
RO - Romania 6
TH - Thailandia 6
CW - ???statistics.table.value.countryCode.CW??? 5
ET - Etiopia 5
PY - Paraguay 5
SI - Slovenia 5
SV - El Salvador 5
AZ - Azerbaigian 4
BG - Bulgaria 4
GR - Grecia 4
HU - Ungheria 4
KE - Kenya 4
LB - Libano 4
BO - Bolivia 3
EE - Estonia 3
KZ - Kazakistan 3
TN - Tunisia 3
UY - Uruguay 3
YE - Yemen 3
AL - Albania 2
BH - Bahrain 2
BS - Bahamas 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
HR - Croazia 2
JO - Giordania 2
KH - Cambogia 2
KW - Kuwait 2
NO - Norvegia 2
PA - Panama 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
Totale 25.385
Città #
Wilmington 4.098
Houston 3.659
Woodbridge 3.367
Singapore 878
Ashburn 774
Fairfield 551
Ann Arbor 473
San Jose 408
Chandler 382
Hong Kong 344
Dallas 251
Seattle 248
Beijing 247
Council Bluffs 213
New York 195
Cambridge 180
Dublin 174
Santa Clara 156
Rome 146
Los Angeles 138
Medford 136
The Dalles 135
Helsinki 131
Ho Chi Minh City 99
Jacksonville 96
Tokyo 79
Moscow 64
Lawrence 63
Lauterbourg 60
Denver 58
Buffalo 56
North Bergen 54
Hanoi 53
São Paulo 51
Chicago 48
Zhengzhou 48
Dearborn 46
London 45
Redwood City 44
Tauranga 42
Toronto 39
Copenhagen 33
Orem 33
Milan 32
Munich 32
Brooklyn 31
Phoenix 31
Amsterdam 30
Nanjing 30
Boardman 29
Kraków 29
Brussels 28
Atlanta 27
Jakarta 27
Montreal 27
Nuremberg 27
Chengdu 24
San Diego 24
Shanghai 24
Shenzhen 24
Johannesburg 23
Seoul 22
Stockholm 22
Taipei 22
Naples 21
Redondo Beach 21
Melbourne 20
Menlo Park 20
Warsaw 20
Suzhou 19
Frankfurt am Main 18
Las Vegas 18
Norwalk 17
San Francisco 17
Chennai 16
Guangzhou 16
Jeddah 16
Columbus 14
Springfield 14
Palo Alto 13
Scottsdale 13
Bassano del Grappa 12
Boston 12
Brasília 12
Mumbai 12
Philadelphia 12
Tanta 12
Florence 11
Lappeenranta 11
Manchester 11
Center 10
Charlotte 10
Chongqing 10
Istanbul 10
Kunming 10
Monte Porzio Catone 10
San José 10
Ankara 9
Cairo 9
Haiphong 9
Totale 19.455
Nome #
Challenges in the treatment of Rheumatoid Arthritis 911
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 678
Complement, infection, and autoimmunity 623
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 545
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 536
Autoantibodies in inflammatory arthritis 529
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 522
Vasculitides and the Complement System: a Comprehensive Review 516
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 486
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 485
Prolactin and natural killer cells: Evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion 483
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 482
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 481
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 480
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 473
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 471
Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study 470
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 468
Auto-reactions, autoimmunity and psoriatic arthritis 449
HELLP syndrome: A complication or a new autoimmune syndrome? 446
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 446
The autoimmune side of hereditary angioedema: Insights on the pathogenesis 443
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 438
The interplay between inflammation and metabolism in rheumatoid arthritis 427
Insights on the role of physical activity in patients with rheumatoid arthritis 423
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 422
Innate Immune System at the Maternal–Fetal Interface: Mechanisms of Disease and Targets of Therapy in Pregnancy Syndromes 408
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 407
Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjögren syndrome. Report of two cases and review of literature 387
Systemic sclerosis: Exploring the potential interplay between thyroid disorders and pregnancy outcome in an Italian cohort 367
Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study 358
Hereditary angioedema and autoimmunity 357
Effects of abatacept on T-lymphocyte sub-populations and immunoglobulins in patients affected by rheumatoid arthritis 352
Factors predicting 2 years of remission and low disease activity in rheumatoid arthritis patients treated with TNF-inhibitors 350
Evidence for the detection of subclinical retinal involvement in systemic Lupus erythematosus and Sjögren syndrome: a potential association with therapies 347
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases 328
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 324
Interaction between microbiome and host genetics in psoriatic arthritis 319
Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study 297
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 287
Take a look at the eyes in Systemic Lupus Erythematosus: A novel point of view 279
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets 272
Response to: 'OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE' by Mizuno et al 266
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 256
Evaluation of retinal microvascular density in patients affected by systemic lupus erythematosus: An optical coherence tomography angiography study 247
A multimodal eye assessment in psoriatic arthritis patients sine-psoriasis: evidence for a potential association with systemic inflammation 238
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay 237
An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis 224
Evaluation of retinal microvascular perfusion in hereditary angioedema: A case-control study 217
Severe lupus nephritis: an unexpected association with Fabry disease 207
Vitamin D deficiency in an Italian cohort of infertile women 199
Assessment of microvascular involvement in lupus nephritis patients by retinal OCT-angiography and kidney biopsies. 196
A rare but fatal behçet variant: the hughes–stovin syndrome—successful case report and new evidence from literature review 196
Reproductive outcomes 20 years after the intravenous immunoglobulin treatment in women with recurrent pregnancy losses 190
Immune checkpoint inhibitors-induced autoimmunity: the impact of gender 183
Observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 183
COVID-19: disCOVering the role of complement system 179
Prospective observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 172
Tackling the autoimmune side in Spondyloarthritis: a systematic review 164
The burden of depressive disorders in musculoskeletal diseases: is there an association between mood and inflammation? 163
Innate lymphoid cells: a potential innate functional equivalent of adaptive cells in infertility and inflammatory arthropathies 158
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary 142
The steroid-sparing effect of JAK inhibitors across multiple patient populations 136
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management 124
Rheumatologist's Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy 122
Study of lncRNAs expression profile in the response to biological drugs in Psoriatic Arthritis: MEG3 could be a potential genomic biomarker of therapy efficacy 121
What's new and what's next for biological and targeted synthetic treatments in psoriatic arthritis? 118
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis 118
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 116
Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections 108
A multilocus genetic study evidences the association of autoimmune-related genes with Psoriatic Arthritis in Italian patients 108
Genetics, epigenetics, and gender impact in axial-spondyloarthritis susceptibility: an update on genetic polymorphisms and their sex related associations 105
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 103
Human Leukocyte Antigen (HLA) Typing Study Identifies Maternal DQ2 Susceptibility Alleles among Infertile Women: Potential Associations with Autoimmunity and Micronutrients 100
Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis 97
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study 96
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts 95
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement 91
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 90
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry 88
Failure and multiple failure for disease modifying antirheumatic drugs in rheumatoid arthritis: Real-life evidence from a tertiary referral center in Italy 87
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry (Internal and Emergency Medicine, (2023), 18, 8, (2231-2243), 10.1007/s11739-023-03408-3) 87
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 87
Overview on the Link Between the Complement System and Auto-Immune Articular and Pulmonary Disease 84
Subclinical microvascular changes in ANCA-vasculitides: the role of optical coherence tomography angiography and nailfold capillaroscopy in the detection of disease-related damage 84
Psoriatic dactylitis: from immunopathogenesis to anti-cytokine and targeted synthetic therapies 81
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome 80
Kidney–Lung Crosstalk in Acute Nephrologic Involvement: Mechanisms, Complement Activation, and Implications for Multiorgan Dysfunction 78
Evaluation of diagnostic and therapeutic delay in patients with rheumatoid arthritis and psoriatic arthritis 78
Micronutrients deficiencies in patients with spondylarthritis: the potential immunometabolic crosstalk in disease phenotype 76
Subclinical signs of retinal involvement in hereditary angioedema 76
Psoriatic Arthritis in Males and Females: Differences and Similarities 71
Unexpected genomic architecture in a sporadic case of C1-INH Hereditary Angioedema: the hidden heritability 69
Pregnancy in women with Hereditary Angioedema due to C1-inhibitor deficiency: Results from the ITACA cohort study on outcome of mothers and children with in utero exposure to plasma-derived C1-inhibitor 66
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 61
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 56
Recent developments for new investigational JAK inhibitors in psoriatic arthritis 50
Reduced retinal microvascular density in patients with mixed connective tissue disease: an exploratory pilot study on the interplay between aging, renal function, and complement system 28
An Italian cartography of VEXAS‐related thrombosis 24
Totale 25.848
Categoria #
all - tutte 71.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.980


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022509 0 0 0 0 37 43 36 39 37 61 83 173
2022/2023955 88 78 49 126 86 204 80 69 95 18 36 26
2023/2024453 38 16 20 13 70 103 14 48 22 25 23 61
2024/20252.445 74 478 311 134 37 233 104 120 198 193 329 234
2025/20265.011 335 239 622 505 467 200 680 494 476 455 296 242
2026/20272.185 290 404 772 637 82 0 0 0 0 0 0 0
Totale 25.848